PD-086 A phase II randomised study of gemcitabine-cisplatin (GP) vs mitomycin-ifosfamide-cisplatin (MIP) as neoadjuvant chemotherapy in resectable stage IIIA non-small cell lung cancer (NSCLC)

✍ Scribed by Brechot, J.; Saintigny, P.; Azorin, J.; Valeyre, D.; Breau, J.; Morere, J.; Gnom,

• Book ID: 118572833
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 134 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(05)80419-2